+499.5%
MRNA vs LVS
-18.2%
+517.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.3% | -1.9% | -2.1% |
| 7D | +5.5% | -1.5% | +7.0% | +6.2% |
| 30D | +158.7% | -3.2% | +162.0% | +164.9% |
| 3M | +182.1% | -12.0% | +194.1% | +190.5% |
| 6M | +151.8% | -19.9% | +171.7% | +160.1% |
| YTD | +393.6% | -30.6% | +424.2% | +408.5% |
| 1Y | +499.5% | -17.7% | +517.2% | +520.5% |
| All | +499.5% | -18.2% | +517.7% | +520.5% |
Cumulative growth
Daily Returns
Daily percentage return beside LVS.
Daily Out/Under-Performance
Portfolio return minus LVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling